Tokyo Tape
Sign in
← Hyuga Primary Care

Quarterly report · Q2

7133.TEDINET S100S8NI
Period2023-04-01 → 2023-09-30
Filed2023-11-13
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 50
MetricValuePeriodScopeSource row
Revenue¥3.9bn2023-04-01 → 2023-09-30StandaloneNet sales
Revenue¥6.7bn2022-04-01 → 2023-03-31StandaloneNet sales (5-year summary)
Revenue¥3.2bn2022-04-01 → 2022-09-30StandaloneNet sales
Operating income¥201m2023-04-01 → 2023-09-30StandaloneOperating income
Operating income¥255m2022-04-01 → 2022-09-30StandaloneOperating income
Ordinary income¥200m2023-04-01 → 2023-09-30StandaloneOrdinary income
Ordinary income¥558m2022-04-01 → 2023-03-31StandaloneOrdinary income loss (5-year summary)
Ordinary income¥263m2022-04-01 → 2022-09-30StandaloneOrdinary income
Profit before tax¥200m2023-04-01 → 2023-09-30StandaloneIncome before income taxes
Profit before tax¥263m2022-04-01 → 2022-09-30StandaloneIncome before income taxes
Net income¥135m2023-04-01 → 2023-09-30StandaloneProfit loss
Net income¥383m2022-04-01 → 2023-03-31StandaloneNet income loss (5-year summary)
Net income¥179m2022-04-01 → 2022-09-30StandaloneProfit loss
Total assets¥4.0bnat 2023-09-30StandaloneAssets
Total assets¥2.9bnat 2023-03-31StandaloneAssets
Total assets¥2.8bnat 2022-09-30StandaloneTotal assets (5-year summary)
Total liabilities¥2.4bnat 2023-09-30StandaloneLiabilities
Total liabilities¥1.4bnat 2023-03-31StandaloneLiabilities
Net assets / equity¥1.6bnat 2023-09-30StandaloneNet assets
Net assets / equity¥1.5bnat 2023-03-31StandaloneNet assets
Net assets / equity¥1.3bnat 2022-09-30StandaloneNet assets (5-year summary)
Cash and deposits¥854mat 2023-09-30StandaloneCash and deposits
Cash and deposits¥568mat 2023-03-31StandaloneCash and deposits
Cash & equivalents¥854mat 2023-09-30StandaloneCash and cash equivalents
Cash & equivalents¥568mat 2023-03-31StandaloneCash and cash equivalents
Cash & equivalents¥680mat 2022-09-30StandaloneCash and cash equivalents
Cash & equivalents¥720mat 2022-03-31dStandaloneCash and cash equivalents
Operating cash flow¥230m2023-04-01 → 2023-09-30StandaloneNet cash provided by used in operating activities
Operating cash flow¥342m2022-04-01 → 2023-03-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥97m2022-04-01 → 2022-09-30StandaloneNet cash provided by used in operating activities
Investing cash flow−¥436m2023-04-01 → 2023-09-30StandaloneNet cash provided by used in investment activities
Investing cash flow−¥383m2022-04-01 → 2023-03-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥193m2022-04-01 → 2022-09-30StandaloneNet cash provided by used in investment activities
Financing cash flow¥492m2023-04-01 → 2023-09-30StandaloneNet cash provided by used in financing activities
Financing cash flow−¥111m2022-04-01 → 2023-03-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥57m2022-04-01 → 2022-09-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥18.822023-04-01 → 2023-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥13.722023-07-01 → 2023-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥53.922022-04-01 → 2023-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥25.332022-04-01 → 2022-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥12.252022-07-01 → 2022-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥17.922023-04-01 → 2023-09-30StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥50.822022-04-01 → 2023-03-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥23.742022-04-01 → 2022-09-30StandaloneDiluted earnings per share (5-year summary)
Equity ratio39.7%at 2023-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio50.9%at 2023-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio46.4%at 2022-09-30StandaloneEquity to asset ratio (5-year summary)
Shares issued7,156,600at 2023-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued3,572,000at 2023-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued3,568,400at 2022-09-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-04-01 → 2023-09-30¥16m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-04-01 → 2023-09-30¥16m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-09-30−¥6m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥230m
jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segmentrevenue2023-04-01 → 2023-09-30¥3.2bn
jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segmentrevenue external2023-04-01 → 2023-09-30¥3.2bn
jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segmentsegment profit2023-04-01 → 2023-09-30¥298m
jpcrp040300-q2r_E37198-000Kirari Primereportable segmentrevenue2023-04-01 → 2023-09-30¥377m
jpcrp040300-q2r_E37198-000Kirari Primereportable segmentrevenue external2023-04-01 → 2023-09-30¥377m
jpcrp040300-q2r_E37198-000Kirari Primereportable segmentsegment profit2023-04-01 → 2023-09-30¥206m
jpcrp040300-q2r_E37198-000Primary Care Homereportable segmentrevenue2023-04-01 → 2023-09-30¥288m
jpcrp040300-q2r_E37198-000Primary Care Homereportable segmentrevenue external2023-04-01 → 2023-09-30¥288m
jpcrp040300-q2r_E37198-000Primary Care Homereportable segmentsegment profit2023-04-01 → 2023-09-30−¥67m
—segment totalrevenue2023-04-01 → 2023-09-30¥3.9bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥3.9bn
—segment totalsegment profit2023-04-01 → 2023-09-30¥436m
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥3.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥3.9bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30¥431m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-09-30¥28m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-09-30¥28m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-09-30¥4m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥192m
jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segmentrevenue2022-04-01 → 2022-09-30¥2.8bn
jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segmentrevenue external2022-04-01 → 2022-09-30¥2.8bn
jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segmentsegment profit2022-04-01 → 2022-09-30¥339m
jpcrp040300-q2r_E37198-000Kirari Primereportable segmentrevenue2022-04-01 → 2022-09-30¥275m
jpcrp040300-q2r_E37198-000Kirari Primereportable segmentrevenue external2022-04-01 → 2022-09-30¥275m
jpcrp040300-q2r_E37198-000Kirari Primereportable segmentsegment profit2022-04-01 → 2022-09-30¥144m
jpcrp040300-q2r_E37198-000Primary Care Homereportable segmentrevenue2022-04-01 → 2022-09-30¥65m
jpcrp040300-q2r_E37198-000Primary Care Homereportable segmentrevenue external2022-04-01 → 2022-09-30¥65m
jpcrp040300-q2r_E37198-000Primary Care Homereportable segmentsegment profit2022-04-01 → 2022-09-30−¥40m
—segment totalrevenue2022-04-01 → 2022-09-30¥3.1bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥3.1bn
—segment totalsegment profit2022-04-01 → 2022-09-30¥443m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥3.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥3.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥447m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 442
ItemContextValueUnit
Cash and cash equivalents (5-year summary)Prior1QuarterInstant_NonConsolidatedMember679958000JPY
Cash and cash equivalents (5-year summary)CurrentQuarterInstant_NonConsolidatedMember853699000JPY
Cash and cash equivalents (5-year summary)Prior1YearInstant_NonConsolidatedMember567688000JPY
Basic earnings loss per share (5-year summary)Prior1QuarterDuration_NonConsolidatedMember12.25
Basic earnings loss per share (5-year summary)CurrentQuarterDuration_NonConsolidatedMember13.72
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember7156600
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember7157200
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant7156600
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant7157200
Number of shares heldCurrentQuarterInstant_No1MajorShareholdersMember1366000
Shareholding ratioCurrentQuarterInstant_No1MajorShareholdersMember0.1909
Number of shares heldCurrentQuarterInstant_No2MajorShareholdersMember900000
Shareholding ratioCurrentQuarterInstant_No2MajorShareholdersMember0.1258
Number of shares heldCurrentQuarterInstant_No3MajorShareholdersMember840000
Shareholding ratioCurrentQuarterInstant_No3MajorShareholdersMember0.1174
Number of shares heldCurrentQuarterInstant_No4MajorShareholdersMember699000
Shareholding ratioCurrentQuarterInstant_No4MajorShareholdersMember0.0978
Number of shares heldCurrentQuarterInstant_No5MajorShareholdersMember500000
Shareholding ratioCurrentQuarterInstant_No5MajorShareholdersMember0.0699
Number of shares heldCurrentQuarterInstant_No6MajorShareholdersMember485000
Shareholding ratioCurrentQuarterInstant_No6MajorShareholdersMember0.0679
Number of shares heldCurrentQuarterInstant_No7MajorShareholdersMember479000
Shareholding ratioCurrentQuarterInstant_No7MajorShareholdersMember0.0670
Number of shares heldCurrentQuarterInstant_No8MajorShareholdersMember197000
Shareholding ratioCurrentQuarterInstant_No8MajorShareholdersMember0.0276
Number of shares heldCurrentQuarterInstant_No9MajorShareholdersMember158000
Shareholding ratioCurrentQuarterInstant_No9MajorShareholdersMember0.0221
Number of shares heldCurrentQuarterInstant_No10MajorShareholdersMember140000
Shareholding ratioCurrentQuarterInstant_No10MajorShareholdersMember0.0196
Number of shares heldCurrentQuarterInstant5767000
Shareholding ratioCurrentQuarterInstant0.8058
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember－
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember－
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember－
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember－
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember21900
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember7133000
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember71330
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember1700
Number of shares issued shares voting rightsCurrentQuarterInstant7156600
Number of voting rights issued shares voting rightsCurrentQuarterInstant71330
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row1Member21900
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row1Member－
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member21900
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.0031
Number of shares held in own name treasury shares etcCurrentQuarterInstant21900
Number of shares held in others names treasury shares etcCurrentQuarterInstant－
Total number of shares held treasury shares etcCurrentQuarterInstant21900
Shareholding ratio treasury shares etcCurrentQuarterInstant0.0031
Cash and depositsPrior1YearInstant_NonConsolidatedMember567688000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2023-03-31pass rounding
balance sheet identitynon_consolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2023-03-31pass
statement vs summary · net assetsnon_consolidated 2023-09-30pass
statement vs summary · operating cash flownon_consolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flownon_consolidated 2023-04-01/2023-09-30pass
statement vs summary · revenuenon_consolidated 2022-04-01/2022-09-30pass
statement vs summary · revenuenon_consolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsnon_consolidated 2023-03-31pass
statement vs summary · total assetsnon_consolidated 2023-09-30pass